Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent
As healthcare continues its shift toward home-based care and self-administration, ensuring patients can use complex drug delivery devices correctly has never been more important. To support this evolving landscape, Noble, an Aptar Pharma company, has been awarded a new U.S. patent for an artificial intelligence-enabled method that uses sound recognition technology to help determine whether a drug delivery or diagnostic device has been operated correctly.
The innovation represents another step forward in Noble’s mission to support confident device use and improve the patient experience throughout the treatment journey.
The Growing Importance of Device Confidence
Today’s therapies increasingly rely on sophisticated drug delivery devices that patients use independently at home. While these devices can improve access and convenience, they also introduce new challenges. Patients must often perform multiple steps correctly to successfully administer medication.
For pharmaceutical manufacturers, healthcare providers, and patients alike, understanding whether those critical steps were completed successfully is essential. Correct device use can influence patient confidence, adherence, and overall treatment success.
Noble’s newly patented technology addresses this challenge through artificial intelligence and acoustic analysis.
How the Technology Works
The patented approach uses acoustic sensing and neural network-based machine learning to analyze sounds generated during device operation. By recognizing and classifying specific sound signatures, the system can help determine whether a drug delivery or diagnostic device has been used correctly.
Rather than relying on visual indicators or hardware modifications, the technology leverages sounds that naturally occur during device operation. This creates opportunities to provide objective feedback and performance verification without adding complexity to the device itself.
The approach may have applications across:
- Device training programs
- Human factors and usability studies
- Performance verification initiatives
- Patient onboarding solutions
- Device support and education programs
By helping identify whether critical steps were completed successfully, the technology can support more informed feedback and a clearer understanding of device use.
Supporting Better Patient Experiences
At Noble, innovation is driven by a simple principle: keeping the patient at the center of every solution.
“As therapies become increasingly self-administered, providing patients with confidence that they are using their devices correctly becomes increasingly important,” said Craig Baker, President of Noble, an Aptar Pharma company. “This patent reflects our commitment to applying innovative technologies in ways that support successful therapy administration and improve the overall patient experience.”
The new patent builds upon Noble’s history of developing patient-centered solutions that help individuals understand, learn and confidently use drug delivery and diagnostic devices.
Part of a Broader Vision for Healthcare Innovation
The patent also reflects Aptar Pharma’s broader commitment to advancing healthcare through innovation. Across Aptar, artificial intelligence is being explored in areas including patient and consumer insights, analytical and compatibility testing, quality prediction, digital health solutions, and advanced data analytics.
Within Noble, these innovations are focused on one critical objective: helping patients navigate increasingly complex therapies with greater confidence and support.
As healthcare continues to evolve, technologies that combine human-centered design, digital innovation, and objective performance feedback have the potential to play an increasingly important role in improving treatment experiences.
Looking Ahead
The issuance of this patent marks an exciting milestone in Noble’s ongoing investment in patient support, device training, and digital innovation. By leveraging artificial intelligence to better understand how devices are used, Noble continues to explore new ways to support successful therapy administration and empower patients throughout their treatment journey.
At the intersection of technology, human factors, and patient support, the goal remains unchanged: helping patients use therapies correctly, confidently, and consistently.
Learn more about the announcement by reading the full press release: View the Press Release